Comparative, Prospective, Open-labeled, Randomized Phase II Study of Cisplatin or Carboplatin With Gemcitabine in Combination With Irinotecan-loaded Beads (LC or ONCOZENE) Versus Cisplatin or Carboplatin With Gemcitabine Alone
Phase of Trial: Phase II
Latest Information Update: 24 Apr 2017
At a glance
- Drugs Irinotecan (Primary) ; Cisplatin; Gemcitabine
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- Acronyms DELTIC
- 17 Aug 2016 Planned End Date changed from 1 Jul 2016 to 1 Jul 2020.
- 17 Aug 2016 Planned primary completion date changed from 1 Jul 2015 to 1 Jul 2020.
- 02 Dec 2014 Planned End Date changed from 1 Jul 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.